A 22-year-old primigravida presents with painless vaginal bleeding and severe hyperemesis gravidarum at 12 weeks gestation. Ultrasound shows a uterus enlarged beyond dates with the characteristic appearance marked **A** in the diagram — grape-like vesicles without a fetal pole. β-hCG is 185,000 mIU/mL. Bilateral ovarian cysts are noted. After suction evacuation and curettage, which of the following is the MOST critical component of post-evacuation surveillance to detect progression to choriocarcinoma?

Explanation

## Why option 1 is correct The structure marked **A** — grape-like chorionic villi — is the pathognomonic sonographic finding of complete hydatidiform mole, which carries a 15–20% risk of progression to choriocarcinoma. The clinical anchor mandates that post-evacuation surveillance must include WEEKLY β-hCG monitoring until undetectable for 3 consecutive weeks, followed by MONTHLY monitoring for 6–12 months. This serial biochemical tracking is the gold standard for detecting rising or persistent β-hCG, which signals either persistent gestational trophoblastic disease (GTD) or evolving choriocarcinoma. Strict contraception during this period is essential because pregnancy would mask a rising β-hCG trend and delay diagnosis of trophoblastic neoplasia. This patient's markedly elevated β-hCG (185,000) and complete mole phenotype (no fetal pole, bilateral theca-lutein cysts) place her at high risk and mandate meticulous follow-up. [Williams Obstetrics 26e] ## Why each distractor is wrong - **Option 2**: Methotrexate is reserved for persistent or rising β-hCG or documented metastatic disease, not administered prophylactically after evacuation of a complete mole. Immediate chemotherapy without evidence of persistent GTD is overtreatment and exposes the patient to unnecessary toxicity. - **Option 3**: Pelvic ultrasound every 2 weeks is not the primary surveillance modality; β-hCG is far more sensitive for detecting trophoblastic activity. Ultrasound may show invasive mole or choriocarcinoma, but biochemical monitoring is the cornerstone of early detection. - **Option 4**: Hysterectomy is not routine after molar evacuation in a young woman and does not eliminate the risk of choriocarcinoma (which can arise from residual trophoblastic tissue or metastatic foci). It is reserved for women who have completed childbearing or have failed medical management. **High-Yield:** Complete hydatidiform mole (46,XX paternal, no fetal pole, "grape-like" villi) requires serial β-hCG surveillance for 6–12 months post-evacuation; rising or persistent β-hCG mandates chemotherapy to prevent choriocarcinoma, which is highly curable (>90%) if caught early. [cite: Williams Obstetrics 26e — Gestational Trophoblastic Disease]